Literature DB >> 19362781

Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.

Joseph K Salama1, Robert I Haddad, Merril S Kies, Paul M Busse, Lei Dong, David M Brizel, Avraham Eisbruch, Roy B Tishler, Andy M Trotti, Adam S Garden.   

Abstract

PURPOSE: The use of induction chemotherapy (IC) for locoregionally advanced head-and-neck cancer is increasing. The response to IC often causes significant alterations in tumor volume and location and shifts in normal anatomy. Proper determination of the radiotherapy (RT) targets after IC becomes challenging, especially with the use of conformal and precision RT techniques. Therefore, a consensus conference was convened to discuss issues related to RT planning and coordination of care for patients receiving IC. METHODS AND MATERIALS: Ten participants with special expertise in the various aspects of integration of IC and RT for the treatment of locoregionally advanced head-and-neck cancer, including radiation oncologists, medical oncologists, and a medical physicist, participated. The individual members were assigned topics for focused, didactic presentations. Discussion was encouraged after each presentation, and recommendations were formulated.
RESULTS: Recommendations and guidelines emerged that emphasize up-front evaluation by all members of the head-and-neck management team, high-quality baseline and postinduction planning scans with the patient in the treatment position, the use of preinduction target volumes, and the use of full-dose RT, even in the face of a complete response.
CONCLUSION: A multidisciplinary approach is strongly encouraged. Although these recommendations were provided primarily for patients treated with IC, many of these same principles apply to concurrent chemoradiotherapy without IC. A rapid response during RT is quite common, requiring the development of two or more plans in a sizeable fraction of patients, and suggesting the need for similar guidance in the rapidly evolving area of adaptive RT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362781     DOI: 10.1016/j.ijrobp.2008.11.059

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

Review 1.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

2.  Effects of nutritional intervention in head and neck cancer patients undergoing radiotherapy: A prospective randomized clinical trial.

Authors:  Wen-Xing Kang; Wentao Li; Shi-Gao Huang; Yazhang Dang; Hongxiang Gao
Journal:  Mol Clin Oncol       Date:  2016-06-30

3.  Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.

Authors:  Charles B Simone; David Ly; Tu D Dan; John Ondos; Holly Ning; Arnaud Belard; John O'Connell; Robert W Miller; Nicole L Simone
Journal:  Radiother Oncol       Date:  2011-06-12       Impact factor: 6.280

4.  Combined paclitaxel, cisplatin and fluorouracil therapy enhances ionizing radiation effects, inhibits migration and induces G0/G1 cell cycle arrest and apoptosis in oral carcinoma cell lines.

Authors:  Silvia Taveira Elias; Gabriel Alvares Borges; Daniela Fortunato Rêgo; Luis Felipe Oliveira E Silva; Samuel Avelino; João Nunes DE Matos Neto; Luiz Alberto Simeoni; Eliete Neves Silva Guerra
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

5.  Radiation induced a supra-additive cytotoxic effect in head and neck carcinoma cell lines when combined with plant extracts from Brazilian Cerrado biome.

Authors:  Silvia T Elias; Gabriel A Borges; Danilo A Amorim; Daniela F Rêgo; Luiz A Simeoni; Dâmaris Silveira; Yris Maria Fonseca-Bazzo; José E Paula; Christopher William Fagg; Ivelone M C Barros; Wenzel C Abreu; Décio S Pinto-Júnior; Pérola O Magalhães; Francisco A R Neves; Adriana Lofrano-Porto; Eliete N S Guerra
Journal:  Clin Oral Investig       Date:  2014-08-07       Impact factor: 3.573

6.  Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer.

Authors:  Molly M McCulloch; Choonik Lee; Benjamin S Rosen; Justin D Kamp; Chrissy M Lockhart; Jae Y Lee; Daniel F Polan; Peter G Hawkins; Carlos J R Anderson; Jolien Heukelom; Jan-Jakob Sonke; Clifton D Fuller; James M Balter; Randall K Ten Haken; Avraham Eisbruch; Kristy K Brock
Journal:  Pract Radiat Oncol       Date:  2019-03-02

Review 7.  Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review.

Authors:  Elaine Barros Ferreira; Christiane Inocêncio Vasques; Rafael Gadia; Raymond Javan Chan; Eliete Neves Silva Guerra; Luis André Mezzomo; Graziela De Luca Canto; Paula Elaine Diniz Dos Reis
Journal:  Support Care Cancer       Date:  2016-12-12       Impact factor: 3.603

8.  IMRT: preliminary results in a series of advanced head-and-neck cancer patients.

Authors:  Antonio Vila Capel; Jorge Vilar Palop; Agustín Pedro Olivé; Alberto Sanchez-Reyes Fernandez; Jordi Vayreda Ribera; Joan Carles Julià Sanahuja; Joaquim Pérez de Olaguer Agustín; Nuria Artola Codina; Luis Miguel Moya Cascant; Esther Rubio Calatayud; Gemma Carrera Domenech
Journal:  Clin Transl Oncol       Date:  2012-07-27       Impact factor: 3.405

9.  Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.

Authors:  Anna Merlotti; Daniela Alterio; Riccardo Vigna-Taglianti; Alessandro Muraglia; Luciana Lastrucci; Roberto Manzo; Giuseppina Gambaro; Orietta Caspiani; Francesco Miccichè; Francesco Deodato; Stefano Pergolizzi; Pierfrancesco Franco; Renzo Corvò; Elvio G Russi; Giuseppe Sanguineti
Journal:  Radiat Oncol       Date:  2014-12-29       Impact factor: 3.481

Review 10.  Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors.

Authors:  Assuntina G Sacco; Francis P Worden
Journal:  Onco Targets Ther       Date:  2016-04-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.